COST Action CA23132
Magnetic Particle Imaging
for next-generation theranostics and medical research
Welcome to COST Action "Magnetic Particle Imaging"
a pioneering initiative focused on advancing the rapidly emerging field of MPI, a non-invasive, cutting-edge biomedical imaging technique. This technique holds enormous potential for clinical diagnosis, therapy, and monitoring treatment outcomes—capabilities that other imaging methods cannot offer.
Latest News & Blogs
nexMPI Cost Action Announces 1st Call for STSMs
First General Meeting of NexMPI (CA23132) Announced
NexMPI COST Action Kick-Off Meeting Successfully Held in Brussels
Working Groups
The NexMPI Action is led by the Management Committee (MC), composed of experts from nanotechnology, physical sciences, chemical sciences, medical engineering, and electrical engineering.
Join a Working Group
To become a member of a WP:
- Verify / update your e-cost profile or create one.
- Submit your application through e-cost portal.
Applications are reviewed regularly by the nexMPI core group and the Working Group leaders. This process typically takes one to three months. Candidates will be notified of the outcome of their application through the e-COST portal.
Explore Funding Opportunities: Application, Evaluation & Eligibility
NexMPI is an open multi-disciplinary network which welcomes new members and offers multiple options for participation and engagement. Individuals who like to engage in the NexMPI network’s work program can apply for becoming part of a working group. NexMPI also offers
grants for the participation in NexMPI events, such as a training schools or workshopw as well as support for individual researchers through Short Term Scientific Missions (STSMs) grants and ITC/YRI conference grants.
M. Irfan and N. Dogan. Comprehensive Evaluation of Magnetic Particle Imaging (MPI) Scanners for Biomedical Applications. IEEE Access, 2022, 10, 86718-86732. https://doi.org/10.1109/ACCESS.2022.3197586.
Our team
Our team is composed of experts from the following expertises:
